BIS Total Return (19 insightful charts) • ETFvest

Sections TR Event vs Risk RS Seasonality Price

This page includes 19 unique total return charts for ProShares UltraShort Nasdaq Biotechnology -2x ETF (BIS).

Tip: It’s not polite to stare. Except with ETFvest charts. Staring at a chart may help you uncover some unique insights.

To provide a sense of the near-term trend, the following chart illustrates the daily total return for ProShares UltraShort Nasdaq Biotechnology -2x ETF (BIS) over the past year.

For a longer-term perspective, the following chart presents total return performance since 2000 (or since inception) for ProShares UltraShort Nasdaq Biotechnology -2x ETF (BIS).

It’s been said that investors should not fight the Fed. To that end, the following chart presents the daily total return performance for ProShares UltraShort Nasdaq Biotechnology -2x ETF (BIS) (blue line) as well as the S&P 500 (gray line) from the last close before the Federal Reserve began increasing the benchmark fed funds rate (March 15, 2022) to today.

War can certainly impact people’s lives, the global order, and a fund’s performance. The following chart presents the daily total return performance for ProShares UltraShort Nasdaq Biotechnology -2x ETF (BIS) (blue line) as well as the S&P 500 (gray line) from the last close before Russia fully invaded Ukraine (February 24, 2022) to today.

The S&P 500 peaked (and entered a bear market) on January 3, 2022. So how has ProShares UltraShort Nasdaq Biotechnology -2x ETF (BIS) (blue line) and the S&P 500 (gray line) performed from that significant S&P 500 peak? The following post-S&P 500 peak chart answers that question.

So how has ProShares UltraShort Nasdaq Biotechnology -2x ETF (BIS) (blue line) and the S&P 500 (gray line) performed from the day before inflation picked up on Febuary 10, 2021 until today? The following post-inflation total return chart illustrates the answer.

The following chart presents the year-to-date total return performance of ProShares UltraShort Nasdaq Biotechnology -2x ETF (BIS) relative to six major asset types.

The following chart presents the year-to-date total return performance of ProShares UltraShort Nasdaq Biotechnology -2x ETF (BIS) relative to six major U.S. stock market indexes.

The following chart presents the year-to-date total return performance of ProShares UltraShort Nasdaq Biotechnology -2x ETF (BIS) relative to stocks of six major countries plus emerging markets.

So how much has ProShares UltraShort Nasdaq Biotechnology -2x ETF (BIS) declined from its peak? When the blue line is at 0%, the ETF is (or was) at its peak. Otherwise, it is (or was) below its peak by the amount indicated on the y-axis. Like all other charts on this page, this chart uses total return data.

The toal return chart below illustrates the performance of ProShares UltraShort Nasdaq Biotechnology -2x ETF (BIS) (blue line) and S&P 500 (gray line) during the Covid bear market.

BIS covid bear market total return chart

The total return chart below illustrates the performance of ProShares UltraShort Nasdaq Biotechnology -2x ETF (BIS) (blue line) and S&P 500 (gray line) during the financial crisis bear market.

BIS financial crisis bear market total return chart

The total return chart below presents the relative strength of ProShares UltraShort Nasdaq Biotechnology -2x ETF (BIS) as compared to the benchmark S&P 500. When the blue line in the chart is trending up, the ETF is outperforming the S&P 500 and when it is moving down it is underperforming.

BIS relative strength total return chart

The following total return chart illustrates the relative strength of ProShares UltraShort Nasdaq Biotechnology -2x ETF (BIS) as compared to the popular/tech-laden Nasdaq 100. When the blue line in the chart is moving up, the ETF is outperforming the Nasdaq 100 and when it is trending down — underperforming.

BIS relative strength vs nasdaq 100 total return chart

The total return chart below presents the relative strength of ProShares UltraShort Nasdaq Biotechnology -2x ETF (BIS) as compared to the Russell 2000 (i.e., small-cap stock index). When the blue line in the chart is working its way higher, the ETF is outperforming the Russell 2000 and when it is headed lower it is underperforming.

BIS relative strength vs russell 2000 total return chart

The following total return chart illustrates the inflation-adjusted performance for ProShares UltraShort Nasdaq Biotechnology -2x ETF (BIS). The U.S. dollar tends to lose purchasing power over time. The following chart adjusts for the ever shrinking dollar so you can see what real total return gains the ETF is actually providing.

BIS inflation-adjusted total return chart

So how is ProShares UltraShort Nasdaq Biotechnology -2x ETF (BIS) performing when priced in that other world currency — gold? The following gold-adjusted chart answers that question.

The following total return chart presents the average year performance for ProShares UltraShort Nasdaq Biotechnology -2x ETF (BIS). There is a season for all things. Well, at least some things.

The total return chart below provides a slightly differnet perspective to seasonality. It illustrates the average year for ProShares UltraShort Nasdaq Biotechnology -2x ETF (BIS) divided by the S&P 500. When the blue line is trending higher, the ETF has outperformed the S&P 500 on average during that part of the year. When the blue line is moving lower, the ETF has underperformed the S&P 500 — on average.